source
- David Chang to hand over the reins at Allogene; Ex-Esperion CEO gets started at PhlowLongtime Allogene CEO David Chang will be stepping down at the end of June. Chang has served as the company’s CEO for the past eight years and will be succeeded by ...Endpoints · 2mo ago↗ source
- Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programsOn the eve of this year’s ASCO annual meeting, Pfizer said it is teaming up with China’s Innovent Biologics to advance a portfolio of 12 early-stage antibody-drug conjugates and multi-specific anti…Endpoints · 2mo ago↗ source
- STAT+: The woman behind the world’s biggest longevity competitionJamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.